2,2'-dipyridyl and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

2,2'-dipyridyl has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies

2,2'-Dipyridyl: A reagent used for the determination of iron.
2,2'-bipyridine : A bipyridine in which the two pyridine moieties are linked by a bond between positions C-2 and C-2'.

Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.

Research

Studies (1)

Authors

Other Studies

1 other study available for 2,2'-dipyridyl and Leukemia, Myelogenous, Chronic, BCR-ABL Positive